ACRES Commercial Realty (ACR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
GAAP net income allocable to common shares was $1.7 million ($0.21 per diluted share) for Q2 2024, with book value per share rising to $27.20 at June 30, 2024.
The commercial real estate loan portfolio stands at $1.7 billion, 79% multifamily, with 94% of loans current on payments.
Portfolio quality is managed through active oversight, with successful resolution of a defaulted retail asset and a $125 million student housing project at FSU 95% pre-leased.
No new CRE loan originations in H1 2024; portfolio decreased by $131.3 million due to payoffs exceeding new fundings.
Focus remains on EAD growth, share repurchases, and prudent capital deployment.
Financial highlights
EAD per share was $0.51 for Q2 2024, up from $0.16 in Q1, driven by real estate operations and lower G&A expenses.
Book value per share was $27.20 at June 30, 2024, up from $24.50 in 2Q23.
Total liquidity at quarter-end was $98.4 million, including $89.6 million in unrestricted cash.
Net CRE loan repayments totaled $61.9 million in Q2 2024.
Net interest income for Q2 2024 was $10.8 million, with a weighted average coupon of 9.13% on the CRE loan portfolio.
Outlook and guidance
Management expects to retain earnings to grow book value and invest in new loan originations as market conditions allow.
Asset sales, including the FSU student housing project, are targeted before the end of 2025, with plans to reinstate the dividend as capital is redeployed.
The company is actively seeking new loan originations as the CLO market and broader conditions improve.
Latest events from ACRES Commercial Realty
- $571M in new loans, $3M net loss, book value up to $30.01, and $1B CRE CLO closed.ACR
Q4 20255 Mar 2026 - Q3 2024 net income rose to $2.8M, book value per share hit $27.92, and liquidity stayed strong.ACR
Q3 202417 Jan 2026 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 202524 Dec 2025 - Book value and EAD rose on asset sales; strong multifamily loans and portfolio growth expected.ACR
Q4 202424 Dec 2025 - Annual meeting to vote on directors, Say on Pay, auditor, and highlight ESG and governance.ACR
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.ACR
Proxy Filing1 Dec 2025 - Q2 2025 saw a net loss, $27.93 book value per share, and a $1.4B CRE loan portfolio.ACR
Q2 202516 Nov 2025 - Q3 net income was $9.8M ($1.34/share), book value rose, and portfolio growth is expected.ACR
Q3 20256 Nov 2025